TRICOR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tricor, and when can generic versions of Tricor launch?
Tricor is a drug marketed by Abbvie and Abbvie Inc and is included in three NDAs. There are two patents protecting this drug and two Paragraph IV challenges.
This drug has one hundred and sixty-four patent family members in twenty-seven countries.
The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tricor
A generic version of TRICOR was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
Summary for TRICOR
International Patents: | 164 |
US Patents: | 2 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 129 |
Clinical Trials: | 20 |
Patent Applications: | 3,665 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRICOR |
Drug Sales Revenues: | Drug sales revenues for TRICOR |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for TRICOR |
What excipients (inactive ingredients) are in TRICOR? | TRICOR excipients list |
DailyMed Link: | TRICOR at DailyMed |



Recent Clinical Trials for TRICOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Institute of General Medical Sciences (NIGMS) | Phase 2/Phase 3 |
The University of Texas Medical Branch, Galveston | Phase 2/Phase 3 |
Shriners Hospitals for Children | Phase 2/Phase 3 |
Pharmacology for TRICOR
Anatomical Therapeutic Chemical (ATC) Classes for TRICOR
Paragraph IV (Patent) Challenges for TRICOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
TRICOR | Tablets | fenofibrate | 48 mg | 021656 | 1 | 2008-07-01 |
TRICOR | Tablets | fenofibrate | 145 mg | 021656 | 1 | 2007-10-19 |
US Patents and Regulatory Information for TRICOR
TRICOR is protected by two US patents.
Patents protecting TRICOR
Nanoparticulate fibrate formulations
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Methods of treatment using nanoparticulate fenofibrate compositions
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: ADJUNCTIVE THERAPY TO DIET IN ADULTS TO REDUCE LDL-C, TRIGLYCERIDES AND APO B, AND INCREASE HDL-C IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA (TYPES IIA, IIB) AND TO TREAT HYPERTRIGLYCERIDEMIA (TYPES IV, V)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | AB | RX | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | |||
Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-002 | Feb 9, 1998 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | AB | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
Abbvie | TRICOR (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 019304-003 | Jun 30, 1999 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRICOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | See Plans and Pricing | See Plans and Pricing |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-002 | Nov 5, 2004 | See Plans and Pricing | See Plans and Pricing |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | See Plans and Pricing | See Plans and Pricing |
Abbvie | TRICOR | fenofibrate | TABLET;ORAL | 021656-001 | Nov 5, 2004 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRICOR
See the table below for patents covering TRICOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H08501073 | See Plans and Pricing | |
European Patent Office | 2266542 | Libération regulée de compositions nanoparticulaires (Controlled release nanoparticulate compositions) | See Plans and Pricing |
European Patent Office | 2283864 | Composition liquide contenant des nanoparticules stabilisées d'une substance active (Liquid dosage compositions fo stable nanoparticulate active agents) | See Plans and Pricing |
Cyprus | 1111344 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |